nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS1—Ifosfamide—testicular cancer	0.237	0.319	CbGbCtD
Diflunisal—PTGS2—Cisplatin—testicular cancer	0.137	0.184	CbGbCtD
Diflunisal—PTGS2—Etoposide—testicular cancer	0.134	0.181	CbGbCtD
Diflunisal—PTGS1—Etoposide—testicular cancer	0.113	0.153	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—testicular cancer	0.0657	0.0884	CbGbCtD
Diflunisal—ALB—Methotrexate—testicular cancer	0.056	0.0753	CbGbCtD
Diflunisal—Anorexia—Ifosfamide—testicular cancer	0.00068	0.00265	CcSEcCtD
Diflunisal—Photosensitivity—Doxorubicin—testicular cancer	0.000677	0.00264	CcSEcCtD
Diflunisal—Decreased appetite—Dactinomycin—testicular cancer	0.000677	0.00264	CcSEcCtD
Diflunisal—Diarrhoea—Vinblastine—testicular cancer	0.000676	0.00264	CcSEcCtD
Diflunisal—Renal impairment—Epirubicin—testicular cancer	0.000675	0.00263	CcSEcCtD
Diflunisal—Fatigue—Dactinomycin—testicular cancer	0.000671	0.00262	CcSEcCtD
Diflunisal—Muscle spasms—Etoposide—testicular cancer	0.000664	0.00259	CcSEcCtD
Diflunisal—Urticaria—Bleomycin—testicular cancer	0.000663	0.00259	CcSEcCtD
Diflunisal—Body temperature increased—Bleomycin—testicular cancer	0.00066	0.00257	CcSEcCtD
Diflunisal—Dizziness—Vinblastine—testicular cancer	0.000654	0.00255	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000643	0.00251	CcSEcCtD
Diflunisal—Feeling abnormal—Dactinomycin—testicular cancer	0.000642	0.0025	CcSEcCtD
Diflunisal—Nausea—Chlorambucil—testicular cancer	0.000641	0.0025	CcSEcCtD
Diflunisal—Paraesthesia—Ifosfamide—testicular cancer	0.000641	0.0025	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000637	0.00248	CcSEcCtD
Diflunisal—Dyspnoea—Ifosfamide—testicular cancer	0.000636	0.00248	CcSEcCtD
Diflunisal—Somnolence—Ifosfamide—testicular cancer	0.000634	0.00247	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00063	0.00246	CcSEcCtD
Diflunisal—Vomiting—Vinblastine—testicular cancer	0.000629	0.00245	CcSEcCtD
Diflunisal—Renal impairment—Doxorubicin—testicular cancer	0.000625	0.00244	CcSEcCtD
Diflunisal—Vertigo—Etoposide—testicular cancer	0.000621	0.00242	CcSEcCtD
Diflunisal—Decreased appetite—Ifosfamide—testicular cancer	0.00062	0.00242	CcSEcCtD
Diflunisal—Headache—Vinblastine—testicular cancer	0.000619	0.00241	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000619	0.00241	CcSEcCtD
Diflunisal—Body temperature increased—Dactinomycin—testicular cancer	0.000616	0.0024	CcSEcCtD
Diflunisal—Fatigue—Ifosfamide—testicular cancer	0.000615	0.0024	CcSEcCtD
Diflunisal—Anaphylactic shock—Cisplatin—testicular cancer	0.000615	0.0024	CcSEcCtD
Diflunisal—Oedema—Cisplatin—testicular cancer	0.000615	0.0024	CcSEcCtD
Diflunisal—Hypersensitivity—Bleomycin—testicular cancer	0.000615	0.0024	CcSEcCtD
Diflunisal—Constipation—Ifosfamide—testicular cancer	0.00061	0.00238	CcSEcCtD
Diflunisal—Loss of consciousness—Etoposide—testicular cancer	0.000607	0.00237	CcSEcCtD
Diflunisal—Thrombocytopenia—Cisplatin—testicular cancer	0.000602	0.00235	CcSEcCtD
Diflunisal—Asthenia—Bleomycin—testicular cancer	0.000599	0.00233	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000595	0.00232	CcSEcCtD
Diflunisal—Hyperhidrosis—Cisplatin—testicular cancer	0.000595	0.00232	CcSEcCtD
Diflunisal—Pruritus—Bleomycin—testicular cancer	0.000591	0.0023	CcSEcCtD
Diflunisal—Feeling abnormal—Ifosfamide—testicular cancer	0.000588	0.00229	CcSEcCtD
Diflunisal—Chest pain—Etoposide—testicular cancer	0.000588	0.00229	CcSEcCtD
Diflunisal—Nausea—Vinblastine—testicular cancer	0.000587	0.00229	CcSEcCtD
Diflunisal—Anorexia—Cisplatin—testicular cancer	0.000586	0.00229	CcSEcCtD
Diflunisal—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000584	0.00227	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000579	0.00226	CcSEcCtD
Diflunisal—Hypersensitivity—Dactinomycin—testicular cancer	0.000574	0.00224	CcSEcCtD
Diflunisal—Gastritis—Epirubicin—testicular cancer	0.000569	0.00222	CcSEcCtD
Diflunisal—Confusional state—Etoposide—testicular cancer	0.000568	0.00221	CcSEcCtD
Diflunisal—Urticaria—Ifosfamide—testicular cancer	0.000567	0.00221	CcSEcCtD
Diflunisal—Body temperature increased—Ifosfamide—testicular cancer	0.000564	0.0022	CcSEcCtD
Diflunisal—Anaphylactic shock—Etoposide—testicular cancer	0.000564	0.0022	CcSEcCtD
Diflunisal—Asthenia—Dactinomycin—testicular cancer	0.000559	0.00218	CcSEcCtD
Diflunisal—Dysuria—Methotrexate—testicular cancer	0.000555	0.00216	CcSEcCtD
Diflunisal—Paraesthesia—Cisplatin—testicular cancer	0.000552	0.00215	CcSEcCtD
Diflunisal—Thrombocytopenia—Etoposide—testicular cancer	0.000552	0.00215	CcSEcCtD
Diflunisal—Dyspnoea—Cisplatin—testicular cancer	0.000549	0.00214	CcSEcCtD
Diflunisal—Hyperhidrosis—Etoposide—testicular cancer	0.000545	0.00212	CcSEcCtD
Diflunisal—Photosensitivity reaction—Methotrexate—testicular cancer	0.000542	0.00211	CcSEcCtD
Diflunisal—Anorexia—Etoposide—testicular cancer	0.000537	0.00209	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000536	0.00209	CcSEcCtD
Diflunisal—Decreased appetite—Cisplatin—testicular cancer	0.000535	0.00208	CcSEcCtD
Diflunisal—Diarrhoea—Dactinomycin—testicular cancer	0.000533	0.00208	CcSEcCtD
Diflunisal—Vomiting—Bleomycin—testicular cancer	0.000531	0.00207	CcSEcCtD
Diflunisal—Rash—Bleomycin—testicular cancer	0.000527	0.00205	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—testicular cancer	0.000526	0.00205	CcSEcCtD
Diflunisal—Dermatitis—Bleomycin—testicular cancer	0.000526	0.00205	CcSEcCtD
Diflunisal—Hypersensitivity—Ifosfamide—testicular cancer	0.000526	0.00205	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000525	0.00205	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—testicular cancer	0.00052	0.00203	CcSEcCtD
Diflunisal—Dysuria—Epirubicin—testicular cancer	0.00052	0.00202	CcSEcCtD
Diflunisal—Stomatitis—Methotrexate—testicular cancer	0.000516	0.00201	CcSEcCtD
Diflunisal—Asthenia—Ifosfamide—testicular cancer	0.000512	0.002	CcSEcCtD
Diflunisal—Sweating—Methotrexate—testicular cancer	0.000508	0.00198	CcSEcCtD
Diflunisal—Photosensitivity reaction—Epirubicin—testicular cancer	0.000507	0.00198	CcSEcCtD
Diflunisal—Feeling abnormal—Cisplatin—testicular cancer	0.000507	0.00198	CcSEcCtD
Diflunisal—Paraesthesia—Etoposide—testicular cancer	0.000506	0.00197	CcSEcCtD
Diflunisal—Pruritus—Ifosfamide—testicular cancer	0.000505	0.00197	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—testicular cancer	0.000505	0.00197	CcSEcCtD
Diflunisal—Dyspnoea—Etoposide—testicular cancer	0.000503	0.00196	CcSEcCtD
Diflunisal—Somnolence—Etoposide—testicular cancer	0.000501	0.00195	CcSEcCtD
Diflunisal—Nausea—Bleomycin—testicular cancer	0.000496	0.00193	CcSEcCtD
Diflunisal—Vomiting—Dactinomycin—testicular cancer	0.000495	0.00193	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—testicular cancer	0.000494	0.00193	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000491	0.00191	CcSEcCtD
Diflunisal—Rash—Dactinomycin—testicular cancer	0.000491	0.00191	CcSEcCtD
Diflunisal—Decreased appetite—Etoposide—testicular cancer	0.00049	0.00191	CcSEcCtD
Diflunisal—Diarrhoea—Ifosfamide—testicular cancer	0.000488	0.0019	CcSEcCtD
Diflunisal—Renal failure—Epirubicin—testicular cancer	0.000487	0.0019	CcSEcCtD
Diflunisal—Body temperature increased—Cisplatin—testicular cancer	0.000486	0.0019	CcSEcCtD
Diflunisal—Fatigue—Etoposide—testicular cancer	0.000486	0.00189	CcSEcCtD
Diflunisal—Jaundice—Epirubicin—testicular cancer	0.000483	0.00188	CcSEcCtD
Diflunisal—Stomatitis—Epirubicin—testicular cancer	0.000483	0.00188	CcSEcCtD
Diflunisal—Constipation—Etoposide—testicular cancer	0.000482	0.00188	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—testicular cancer	0.000481	0.00187	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—testicular cancer	0.000475	0.00185	CcSEcCtD
Diflunisal—Sweating—Epirubicin—testicular cancer	0.000475	0.00185	CcSEcCtD
Diflunisal—Haematuria—Epirubicin—testicular cancer	0.000472	0.00184	CcSEcCtD
Diflunisal—Dizziness—Ifosfamide—testicular cancer	0.000472	0.00184	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000469	0.00183	CcSEcCtD
Diflunisal—Feeling abnormal—Etoposide—testicular cancer	0.000464	0.00181	CcSEcCtD
Diflunisal—Nausea—Dactinomycin—testicular cancer	0.000463	0.0018	CcSEcCtD
Diflunisal—Agranulocytosis—Epirubicin—testicular cancer	0.000462	0.0018	CcSEcCtD
Diflunisal—Gastrointestinal pain—Etoposide—testicular cancer	0.000461	0.0018	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—testicular cancer	0.000458	0.00178	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000454	0.00177	CcSEcCtD
Diflunisal—Vomiting—Ifosfamide—testicular cancer	0.000454	0.00177	CcSEcCtD
Diflunisal—Hypersensitivity—Cisplatin—testicular cancer	0.000453	0.00177	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—testicular cancer	0.000451	0.00176	CcSEcCtD
Diflunisal—Rash—Ifosfamide—testicular cancer	0.00045	0.00175	CcSEcCtD
Diflunisal—Dermatitis—Ifosfamide—testicular cancer	0.00045	0.00175	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—testicular cancer	0.000449	0.00175	CcSEcCtD
Diflunisal—Urticaria—Etoposide—testicular cancer	0.000448	0.00174	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—testicular cancer	0.000447	0.00174	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—testicular cancer	0.000447	0.00174	CcSEcCtD
Diflunisal—Body temperature increased—Etoposide—testicular cancer	0.000446	0.00174	CcSEcCtD
Diflunisal—Hepatitis—Epirubicin—testicular cancer	0.000445	0.00173	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—testicular cancer	0.000443	0.00173	CcSEcCtD
Diflunisal—Asthenia—Cisplatin—testicular cancer	0.000441	0.00172	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—testicular cancer	0.000439	0.00171	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—testicular cancer	0.000437	0.0017	CcSEcCtD
Diflunisal—Visual impairment—Epirubicin—testicular cancer	0.000429	0.00167	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—testicular cancer	0.000428	0.00167	CcSEcCtD
Diflunisal—Nausea—Ifosfamide—testicular cancer	0.000424	0.00165	CcSEcCtD
Diflunisal—Diarrhoea—Cisplatin—testicular cancer	0.000421	0.00164	CcSEcCtD
Diflunisal—Erythema multiforme—Epirubicin—testicular cancer	0.00042	0.00164	CcSEcCtD
Diflunisal—Hypersensitivity—Etoposide—testicular cancer	0.000415	0.00162	CcSEcCtD
Diflunisal—Tinnitus—Epirubicin—testicular cancer	0.000415	0.00162	CcSEcCtD
Diflunisal—Flushing—Epirubicin—testicular cancer	0.000413	0.00161	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—testicular cancer	0.000411	0.0016	CcSEcCtD
Diflunisal—Asthenia—Etoposide—testicular cancer	0.000404	0.00158	CcSEcCtD
Diflunisal—Pruritus—Etoposide—testicular cancer	0.000399	0.00155	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—testicular cancer	0.000397	0.00155	CcSEcCtD
Diflunisal—Vomiting—Cisplatin—testicular cancer	0.000391	0.00152	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—testicular cancer	0.00039	0.00152	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—testicular cancer	0.000389	0.00152	CcSEcCtD
Diflunisal—Rash—Cisplatin—testicular cancer	0.000388	0.00151	CcSEcCtD
Diflunisal—Dermatitis—Cisplatin—testicular cancer	0.000388	0.00151	CcSEcCtD
Diflunisal—Diarrhoea—Etoposide—testicular cancer	0.000386	0.0015	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—testicular cancer	0.000384	0.0015	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—testicular cancer	0.000382	0.00149	CcSEcCtD
Diflunisal—Flatulence—Epirubicin—testicular cancer	0.000381	0.00149	CcSEcCtD
Diflunisal—Tension—Epirubicin—testicular cancer	0.00038	0.00148	CcSEcCtD
Diflunisal—Nervousness—Epirubicin—testicular cancer	0.000376	0.00147	CcSEcCtD
Diflunisal—Dizziness—Etoposide—testicular cancer	0.000373	0.00145	CcSEcCtD
Diflunisal—Muscle spasms—Epirubicin—testicular cancer	0.000372	0.00145	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—testicular cancer	0.000372	0.00145	CcSEcCtD
Diflunisal—Nausea—Cisplatin—testicular cancer	0.000365	0.00142	CcSEcCtD
Diflunisal—Vision blurred—Epirubicin—testicular cancer	0.000365	0.00142	CcSEcCtD
Diflunisal—Vomiting—Etoposide—testicular cancer	0.000358	0.0014	CcSEcCtD
Diflunisal—Rash—Etoposide—testicular cancer	0.000355	0.00138	CcSEcCtD
Diflunisal—Dermatitis—Etoposide—testicular cancer	0.000355	0.00138	CcSEcCtD
Diflunisal—Headache—Etoposide—testicular cancer	0.000353	0.00138	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—testicular cancer	0.000353	0.00138	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—testicular cancer	0.000352	0.00137	CcSEcCtD
Diflunisal—Tension—Doxorubicin—testicular cancer	0.000352	0.00137	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—testicular cancer	0.000348	0.00136	CcSEcCtD
Diflunisal—Vertigo—Epirubicin—testicular cancer	0.000348	0.00136	CcSEcCtD
Diflunisal—Syncope—Epirubicin—testicular cancer	0.000347	0.00135	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—testicular cancer	0.000344	0.00134	CcSEcCtD
Diflunisal—Palpitations—Epirubicin—testicular cancer	0.000342	0.00133	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—testicular cancer	0.00034	0.00133	CcSEcCtD
Diflunisal—Loss of consciousness—Epirubicin—testicular cancer	0.00034	0.00133	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—testicular cancer	0.000338	0.00132	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—testicular cancer	0.000338	0.00132	CcSEcCtD
Diflunisal—Nausea—Etoposide—testicular cancer	0.000335	0.0013	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—testicular cancer	0.000331	0.00129	CcSEcCtD
Diflunisal—Chest pain—Epirubicin—testicular cancer	0.00033	0.00128	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—testicular cancer	0.000326	0.00127	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—testicular cancer	0.000322	0.00125	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—testicular cancer	0.000322	0.00125	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—testicular cancer	0.000321	0.00125	CcSEcCtD
Diflunisal—Confusional state—Epirubicin—testicular cancer	0.000319	0.00124	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—testicular cancer	0.000317	0.00123	CcSEcCtD
Diflunisal—Anaphylactic shock—Epirubicin—testicular cancer	0.000316	0.00123	CcSEcCtD
Diflunisal—Oedema—Epirubicin—testicular cancer	0.000316	0.00123	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—testicular cancer	0.000315	0.00123	CcSEcCtD
Diflunisal—Shock—Epirubicin—testicular cancer	0.000311	0.00121	CcSEcCtD
Diflunisal—Thrombocytopenia—Epirubicin—testicular cancer	0.000309	0.00121	CcSEcCtD
Diflunisal—Hyperhidrosis—Epirubicin—testicular cancer	0.000305	0.00119	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—testicular cancer	0.000305	0.00119	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—testicular cancer	0.000305	0.00119	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—testicular cancer	0.000303	0.00118	CcSEcCtD
Diflunisal—Anorexia—Epirubicin—testicular cancer	0.000301	0.00117	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—testicular cancer	0.000301	0.00117	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—testicular cancer	0.0003	0.00117	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—testicular cancer	0.000297	0.00116	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—testicular cancer	0.000295	0.00115	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—testicular cancer	0.000293	0.00114	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—testicular cancer	0.000292	0.00114	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—testicular cancer	0.000292	0.00114	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—testicular cancer	0.000291	0.00113	CcSEcCtD
Diflunisal—Shock—Doxorubicin—testicular cancer	0.000288	0.00112	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—testicular cancer	0.000286	0.00112	CcSEcCtD
Diflunisal—Insomnia—Epirubicin—testicular cancer	0.000286	0.00111	CcSEcCtD
Diflunisal—Paraesthesia—Epirubicin—testicular cancer	0.000284	0.00111	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—testicular cancer	0.000283	0.0011	CcSEcCtD
Diflunisal—Dyspnoea—Epirubicin—testicular cancer	0.000282	0.0011	CcSEcCtD
Diflunisal—Somnolence—Epirubicin—testicular cancer	0.000281	0.00109	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—testicular cancer	0.000279	0.00109	CcSEcCtD
Diflunisal—Feeling abnormal—Methotrexate—testicular cancer	0.000278	0.00108	CcSEcCtD
Diflunisal—Dyspepsia—Epirubicin—testicular cancer	0.000278	0.00108	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—testicular cancer	0.000276	0.00108	CcSEcCtD
Diflunisal—Decreased appetite—Epirubicin—testicular cancer	0.000275	0.00107	CcSEcCtD
Diflunisal—Fatigue—Epirubicin—testicular cancer	0.000272	0.00106	CcSEcCtD
Diflunisal—Constipation—Epirubicin—testicular cancer	0.00027	0.00105	CcSEcCtD
Diflunisal—Urticaria—Methotrexate—testicular cancer	0.000268	0.00105	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—testicular cancer	0.000267	0.00104	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—testicular cancer	0.000264	0.00103	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—testicular cancer	0.000263	0.00102	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—testicular cancer	0.000261	0.00102	CcSEcCtD
Diflunisal—Feeling abnormal—Epirubicin—testicular cancer	0.00026	0.00101	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—testicular cancer	0.00026	0.00101	CcSEcCtD
Diflunisal—Gastrointestinal pain—Epirubicin—testicular cancer	0.000258	0.00101	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—testicular cancer	0.000257	0.001	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—testicular cancer	0.000254	0.00099	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—testicular cancer	0.000252	0.000982	CcSEcCtD
Diflunisal—Urticaria—Epirubicin—testicular cancer	0.000251	0.000978	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—testicular cancer	0.00025	0.000974	CcSEcCtD
Diflunisal—Body temperature increased—Epirubicin—testicular cancer	0.00025	0.000973	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—testicular cancer	0.000249	0.000969	CcSEcCtD
Diflunisal—Asthenia—Methotrexate—testicular cancer	0.000242	0.000944	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—testicular cancer	0.000241	0.000939	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000239	0.000932	CcSEcCtD
Diflunisal—Pruritus—Methotrexate—testicular cancer	0.000239	0.000931	CcSEcCtD
Diflunisal—Hypersensitivity—Epirubicin—testicular cancer	0.000233	0.000907	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—testicular cancer	0.000232	0.000905	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—testicular cancer	0.000231	0.000901	CcSEcCtD
Diflunisal—Diarrhoea—Methotrexate—testicular cancer	0.000231	0.0009	CcSEcCtD
Diflunisal—Asthenia—Epirubicin—testicular cancer	0.000227	0.000883	CcSEcCtD
Diflunisal—Pruritus—Epirubicin—testicular cancer	0.000224	0.000871	CcSEcCtD
Diflunisal—Dizziness—Methotrexate—testicular cancer	0.000223	0.00087	CcSEcCtD
Diflunisal—Diarrhoea—Epirubicin—testicular cancer	0.000216	0.000842	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—testicular cancer	0.000215	0.000839	CcSEcCtD
Diflunisal—Vomiting—Methotrexate—testicular cancer	0.000215	0.000837	CcSEcCtD
Diflunisal—Rash—Methotrexate—testicular cancer	0.000213	0.00083	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—testicular cancer	0.000213	0.000829	CcSEcCtD
Diflunisal—Headache—Methotrexate—testicular cancer	0.000212	0.000824	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—testicular cancer	0.00021	0.000817	CcSEcCtD
Diflunisal—Dizziness—Epirubicin—testicular cancer	0.000209	0.000814	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—testicular cancer	0.000207	0.000806	CcSEcCtD
Diflunisal—Vomiting—Epirubicin—testicular cancer	0.000201	0.000783	CcSEcCtD
Diflunisal—Nausea—Methotrexate—testicular cancer	0.000201	0.000782	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—testicular cancer	0.0002	0.000779	CcSEcCtD
Diflunisal—Rash—Epirubicin—testicular cancer	0.000199	0.000776	CcSEcCtD
Diflunisal—Dermatitis—Epirubicin—testicular cancer	0.000199	0.000776	CcSEcCtD
Diflunisal—Headache—Epirubicin—testicular cancer	0.000198	0.000771	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—testicular cancer	0.000193	0.000753	CcSEcCtD
Diflunisal—Nausea—Epirubicin—testicular cancer	0.000188	0.000731	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—testicular cancer	0.000186	0.000724	CcSEcCtD
Diflunisal—Rash—Doxorubicin—testicular cancer	0.000184	0.000718	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—testicular cancer	0.000184	0.000718	CcSEcCtD
Diflunisal—Headache—Doxorubicin—testicular cancer	0.000183	0.000714	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—testicular cancer	0.000174	0.000677	CcSEcCtD
